🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 1 first-in-human single ascending dose study will be a randomize...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2015-08
Trial ID
NCT02531815
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, and pharma...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT02140125
Primary study objective: To confirm the efficacy of HBM9161 subcutaneous in...
Status
Completed
Location
Huashan Hospital, Fudan University
Start Date
2021-09-25
Trial ID
NCT05039190
Treatments Being Tested
This study will evaluate upadacitinib compared to dupilumab (Dupixent®) in ...
Status
Completed
Location
Clinical Research Center AL /ID# 210277
Start Date
2019-02-21
Trial ID
NCT03738397
Treatments Being Tested
This study is researching an experimental drug called ALN-PNP. This study i...
Status
Completed
Location
Chungbuk National University Hospital
Start Date
2024-05-21
Trial ID
NCT06024408
TRIAL DESIGN 1. Description This is a 18-month, double-blind, randomized, ...
Status
Completed
Location
Leeds Teaching Hospital HNS Trust
Start Date
2006-09
Trial ID
NCT01303874
Treatments Being Tested
The primary objective of this study is to evaluate the immune response afte...
Status
Completed
Location
Harrison Clinical Research GmbH
Start Date
2006-04
Trial ID
NCT00316524
Treatments Being Tested
The purpose of the study is to assess the safety and efficacy of adalimumab...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00235859
Treatments Being Tested
The purpose of this study is to determine whether denosumab compared to pla...
Status
Completed
Location
Research Site
Start Date
2006-12-18
Trial ID
NCT00556374
Treatments Being Tested
This study has 2 parts: First part is the main study and second part is the...
Status
Active Not Recruiting
Location
Univ of Alabama Birmingham
Start Date
2022-11-01
Trial ID
NCT05567796
Treatments Being Tested